New Product PlanningSUMMIT

Improve early-stage decision-making, optimize lifecycle management and tailor product plans to ensure the successful commercialization of new drugs

December 7-8, 2017Revere Hotel Boston Common | Boston, MA

David Xu, Executive Director, Head of New Product Planning, PURDUE PHARMA

Gary L. Pyner, Chief Commercial Officer, ASKLEPION PHARMACEUTICALS

Kasia Hein-Peters, Vaxelis Head of Marketing, SANOFI PASTEUR

Ira Klein, M.D., MBA, FACP,Senior Director of Healthcare Quality Strategy, Strategic Customer Group,JANSSEN PHARMACEUTICALS

Event Highlights Develop effective strategies for collaboration between commercial

and R&D teams to allow for critical inputs in early-stage decision-making

Ensure regional needs are being incorporated and addressed in the global product development process

Sort through multiple indication opportunities and build business cases to support new product development in a small company environment

Assess the benefits of developing a market access plan in the early stages of product development

Explore how new product planning groups can go beyond the traditional mold to provide additional value to their organization

Sponsor

Katja Wachtendonk, Global Director New Products, NOVARTIS

Lisa Johnson-Pratt, M.D., Head, Early Pipeline Commercial and Oncology Strategy, GLAXOSMITHKLINE

CONFERENCE CHAIRPERSON

2nd

Elise Brownell, Ph.D., Executive Vice President, Operations and Project Management,AMARANTUS BIOSCIENCE HOLDINGS

R&D

Market Research

Competitive Intelligence

Commercial Strategy

Market Access

Launch Management

Marketing

New Product Planning

Dear Colleague,Successful product launches are often the culmination of years of research and analysis. Multiple functional teams provide their insight and analysis at various points of a product’s lifecycle to help navigate the competitive landscape and assess its commercial viability. Depending on the size and culture of a company, these decision-making committees can include representatives that have overseen the development of a product from discovery all the way to Phase 2, as well as some executives that get involved closer to its launch.

As the healthcare landscape continues to evolve and include a growing number of key decision-makers, life science companies are increasingly required to demonstrate the value of a product at different milestones. New product planning professionals play a key role in streamlining communications across functional lines and maintaining product-specific knowledge throughout the different stages of development to better position a product in the marketplace.

The 2nd New Product Planning Summit serves as a platform for product development and brand commercialization teams to learn how to improve early-stage decision-making, optimize lifecycle management, tailor a product plan using commercial insights to gain a competitive advantage in the marketplace and ensure the successful commercialization of a new product.

We look forward to welcoming you to Boston in December!

Sincerely,

Zohaib Sheikh

Zohaib SheikhSenior Conference DirectorExL Events, a division of Questex, LLC

WHO SHOULD ATTEND:This conference is designed for representatives from pharmaceutical and biotechnology companies with responsibilities in the following areas:

• New Product Planning/Commercialization/Development

• Commercial Assessment/Strategy• Competitive/Business Intelligence• Market Research• Business/Strategic Planning• Global/Strategic Marketing• Product Development• Portfolio/Product/Brand/Lifecycle

Management• Research and Development• Brand Commercialization• Health Economics and Outcomes Research• Market Access/Pricing• Reimbursement Strategy• Medical Strategy• Regulatory Affairs/Compliance• Medical Affairs• Intellectual Property/Legal• Scientific/Medical Communication• Publication Planning• Managed Markets/Care Strategy• Business Development• Licensing

This conference is also of interest to:• Competitive Intelligence Service Providers• Market Research Providers• Commercial Strategy Consultants• Product Launch Advisors• New Product Marketing Consultants• Business Intelligence Services• Business Insight Services• Data Analytics Service Providers

VENUERevere Hotel Boston Common200 Stuart Street | Boston, MA 02116To make reservations, guests can call 877-673-8373 and request the negotiated rate for ExL’s December Meetings. You may also make reservations online at http://bit.ly/2tMZv0X. The group rate is available until November 15, 2017. Please book your room early, as rooms available at this rate are limited.

*ExL Events is not a affiliated with Exhibition Housing Management (EHM)/Exhibitors HousingServices (EHS) or any third-party booking agencies, bureaus or travel companies. ExL Events is affiliated with event company Questex, LLC. In the event that an outside party contacts you for any type of hotel or travel arrangements, please disregard these solicitations and kindly email us at info@exlevents.com. ExL has not authorized these companies to contact you and we do not verify the legitimacy of the services or rates offered. Please book your guest rooms through ExL’s reserved guest room block using the details provided.

SPONSORSHIP AND EXHIBITION OPPORTUNITIESDo you want to spread the word about your organization’s solutions and services to potential clients attending this event? Take advantage of the opportunity to exhibit, underwrite an educational session, host a networking event or distribute promotional items to attendees. ExL Events will work closely with you to customize a package that will suit all of your needs. To learn more about these opportunities, please call 201 871 0474 or email register@pmaconference.com

New Product PlanningSUMMIT

Thursday, December 7, 2017 Day One

8:00 Registration and Continental Breakfast

8:45 Chairperson’s Opening RemarksKatja Wachtendonk, Global Director New Products, NOVARTIS

9:00 Optimize the R&D-Commercial Interface to Deliver Drugs of Value to Customers• Discuss the importance of developing a new asset in

the context of a preexisting disease and/or therapeuticarea strategy

• Understand the criticality of defining an asset’s value asearly as possible in the drug development process

• Describe the role of the Target Product Profile in aligningthe expectations of R&D and commercial parts of theorganization

• Address the role of inflection points and go-no-go criteriain creating a “fast to fail” culture

Lisa Johnson-Pratt, M.D., Head, Early Pipeline Commercial and Oncology Strategy, Global Franchise, GSK

9:45 Strategically Utilize Market Research and Competitive Intelligence to Support Planning and Decision-Making for New Products• Recognize the difference between information in the public

domain, traditional market research, and competitiveintelligence that is relevant to the needs of your product

• Create a streamlined process for intelligence gatheringthat effectively supports big picture decision-making andleadership communication

• Hear best practices for collaborating with cross-functionalpartners to ensure the successful development of a newproduct

David Staknis, Global Health and Life Sciences Practice Lead, FULD + COMPANY

10:30 Networking Break

11:00 Assessing Value and Key Drivers Impacting Commercialization of New Products• Discuss the Quality Payment Program construct from CMS

that informs commercialization of a new product from avalue and payment perspective

• Examine which market factors must be considered toimpact commercialization in this new value-based world

• Explore the value-based priorities and challenges for drugcommercialization in the present and future

Ira Klein, Senior Director of Quality, Strategic Customer Group, JANSSEN

11:45 Effectively Manage Product Transitions From New Product Planning to Launch Teams• Consider the different skill sets of new product planning

and launch teams• Identify and measure specific factors across the two

teams to assess product drivers and risks• Ensure the continuity and transference of market research

to the marketing lead• Learn how to smoothly transition all intellectual property

without losing any product-specific knowledge/information

Charles Rosensweig, Senior Director, New Product Development, TEVA CANADA INNOVATION

12:30 Luncheon

1:30 Planning With the End in Mind: Evaluating Lifecycle Management Strategies As Part of New Product Planning • Evaluate lifecycle management strategies• Understand the role of brand to authorized generic

strategies• Collaborate with cross-functional partners to evaluate and

ensure success• Leverage thought leader feedback to develop and finalize

strategiesKristin Squires, Senior Director, Marketing, Dermatology, SUN PHARMA

2:15 Creating a Unique Service Model Supporting Patient Acquisition and Retention• Create an infrastructure that removes barriers to new

patient starts and existing patient retention• Contribute to revenue goals via innovative programs

supporting acquisition and retention• Utilize advocacy partnerships to develop impactful

programs• Understand HCP and payer impacts to ensure desired

patient outcomesLiam Moy, Associate Director – New Product Planning, BIOGEN

3:00 Networking Break

3:30 Interactive Learning Exercise• Conduct a poll of the attendees on the core responsibilities

for new product planning professionals at othercompanies

• Examine other areas where NPP professionals can benefitthe organization

• Share best practices and strategies as a group forproblems suggested by your peers

Elise Brownell, Senior Vice President, Operations and Program Management, AMARANTUS BIOSCIENCE HOLDINGS

4:15 Explore How the Roles and Responsibilities of New Product Planning Teams Differ Across Therapeutic Areas and Companies• Recognize key members of the product development team,

their respective roles, and responsibilities• Review the chief steps of the new product planning

process• Learn how practices can change depending on company

size and culture• Discover the common mistakes and pitfalls of new

product developmentElise Brownell, Senior Vice President, Operations and Program Management, AMARANTUS BIOSCIENCE HOLDINGSSharlene Cirillo, Vice President of Marketing, CHURCHILL PHARMACEUTICALS

5:00 Day One Concludes

PAN

EL

Friday, December 8, 2017 Day Two

8:00 Continental Breakfast

9:00 Chairperson’s Recap of Day OneKatja Wachtendonk, Global Director New Products, NOVARTIS

9:15 New Product Positioning to Ensure You Are Getting It Right From the Start• Discuss the concept of “positioning” and the core

elements of a positioning statement• Review the process for developing and validating

positioning• Discuss examples of well-positioned productsMichael P. Bentivegna, Vice President, Commercial Development and Lifecycle Innovation, ZOETIS

10:00 Develop a “Glocal” Marketing Communications Strategy That Is Globally Consistent and Locally Relevant• Understand the difference in resources available to

country teams compared to global teams and how theyoften follow opinion-based strategies instead of leveragingmarket research effectively

• Adjust the global marketing communications strategy tothe needs of the affiliates and local elements

• Learn how to develop impactful messaging acrossdifferent cultures

• Strike a balance between highly centralized and localizedcompany structures and communication strategies

Kasia Hein-Peters, Vaxelis (PR51) Marketing Head, SANOFI PASTEUR

10:45 Networking Break

11:15 Optimize the Target Product Profile to Drive Commercial Success• Establish a favorable time and robust process to

successfully develop a target product profile• Involve commercial stakeholders early on to address gaps

before the R&D team outlines a full clinical developmentprogram

• Prioritize key features and attributes of the intendedend product

• Enhance the label to ensure it addresses unmet patientneeds and has a value proposition that resonates withhealthcare providers and payers

If you are interested in leading this session, please contact David Finkel at dfinkel@exlevents.com.

12:00 Optimize Asset Value in Development• Examine some of the key factors that drive the commercial

success of an asset• Explore how new product planning can shape these key

success factors in development• Understand how we measure the success of new product

planningDavid Xu, Executive Director, Head of New Product Planning, PURDUE PHARMA

12:45 Luncheon

1:45 Build a Business Case for New Product Concepts in a Small Company Environment• Demonstrate the value of interfacing with R&D teams early

in the process of new product planning• Lead cross-functional teams in the evaluation of multiple

targets and indications• Construct effective business cases for senior

management to support new product conceptsTony Russell, Senior Director, Product Strategy and Commercial Planning, THERAVANCE BIOPHARMA

2:30 New Product Planning and Market Interface• Assess the scalability of this checklist based on company

size and resources• Explore the pros and cons of conducting certain activities

at various points in a product lifecycle• Set up a new product planning matrix that supports

the needs of inter-disciplinary teams such as R&D andcommercial

• Establish a secondary course of action into yourNPP process

Gary Pyner, Chief Commercial Officer, ASKLEPION PHARMACEUTICALS

3:15 Chairperson’s Closing RemarksKatja Wachtendonk, Global Director New Products, NOVARTIS

3:30 Conference Concludes

“The greatest benefit of attending this conference was hearing a broad perspective of the new product planning role across the product development cycle and some of the tools being used for decision-making.”

—Director, New Products and Projects, BRISTOL-MYERS SQUIBB

“The attendees were engaged and interested throughout and the speakers provided excellent presentations. It was great to meet others in this field, establish contacts for future collaborations, and learn strategies that I can implement into my work immediately.”

—Senior Director, Research and New Product Planning, ALCRESTA, INC.

TERMS AND CONDITIONS: By registering for an ExL Events (“ExL”) event, you agree to the following set of terms and conditions listed below:REGISTRATION FEE: The fee includes the conference‚ all program materials‚ and designated continental breakfasts‚ lunches and refreshments.PAYMENT: Make checks payable to ExL Events and write C884 on your check. You may also use Visa, MasterCard, Discover or American Express. Payments must be received in full by the conference date. Any discount applied cannot be combined with any other offer and must be paid in full at the time of order. Parties must be employed by the same organization and register simultaneously to realize group discount pricing options.**Please Note: There will be an administrative charge of $300 to substitute, exchange and/or replace attendance badges with a colleague within five business days of any ExL conference.**CANCELLATION AND REFUND POLICY: If you cancel your registration for an upcoming ExL event, the following policies apply, derived from the Start Date of the event:• Four weeks or more: A full refund (minus a $295 processing fee) or a voucher to

another ExL event valid for 12 months from the voucher issue date.• Less than four weeks: A voucher to another ExL event valid for 12 months from the

voucher issue date.• Five days or less: A voucher (minus a $395 processing and documentation fee) to

another ExL event valid for 12 months from the voucher issue date.

CREDIT VOUCHERS: Credit vouchers are valid for 12 months from date of issue. Credit vouchers are valid toward one (1) ExL event of equal or lesser value. If the full amount of said voucher is not used at time of registration, any remaining balance is not applicable now or in the future. Once a credit voucher has been applied toward a future event, changes cannot be made. In the event of cancellation on the attendees’ behalf, the credit voucher will no longer be valid.

ExL Events does not and is not obligated to provide a credit voucher to registered attendee(s) who do not attend the event they registered for unless written notice of intent to cancel is received and confirmed prior to the commencement of the event.SUBSTITUTION CHARGES: There will be an administrative charge of $300 to substitute, exchange and/or replace attendee badges with a colleague occurring within five business days of the conference. ExL Events reserves the right to cancel any conference it deems necessary and will not be responsible for airfare‚ hotel or any other expenses incurred by registrants.ExL Events’ liability is limited to the conference registration fee in the event of a cancellation and does not include changes in program date‚ content‚ speakers and/or venue.*The opinions of ExL’s conference speakers do not necessarily reflect those of the companies they represent, nor ExL Events.Please Note: Speakers and agenda are subject to change without notice. In the event of a speaker cancellation, significant effort to find a suitable replacement will be made. The content in ExL slide presentations, including news, data, advertisements and other information, is provided by ExL’s designated speakers and is designed for informational purposes for its attendees. It is NOT INTENDED for purposes of copywriting or redistribution to other outlets without the express written permission of ExL’s designated speaking parties. Neither ExL nor its content providers and/or speakers and attendees shall be liable for any errors, inaccuracies or delays in content, or for any actions taken in reliance thereon. EXL EVENTS EXPRESSLY DISCLAIMS ALL WARRANTIES, EXPRESSED OR IMPLIED, AS TO THE ACCURACY OF ANY CONTENT PROVIDED, OR AS TO THE FITNESS OF THE INFORMATION FOR ANY PURPOSE. Although ExL makes reasonable efforts to obtain reliable content from third parties, ExL does not guarantee the accuracy of, or endorse the views or opinions given by any third-party content provider. ExL presentations may point to other websites that may be of interest to you, however ExL does not endorse or take responsibility for the content on such other sites.

Registration Fees for Attending ExL’s 2nd New Product Planning Summit

EARLY BIRD PRICING - Register by Friday October 20, 2017

Conference: $1,895

STANDARD PRICING - Register After Friday, October 20, 2017

Conference: $2,095

ONSITE PRICING

Conference: $2,195

Group Discount ProgramOffers may not be combined. Early Bird rates do not apply. To find out more about how you can take advantage of these group discounts, please call 201 871 0474. Save 25% per person when registering four For every three simultaneous registrations from your company, you will receive a fourth complimentary registration to the program (must register four at one time). This is a savings of 25% per person.

Save 15% per person when registering three Can only send three? You can still save 15% off of every registration.

Media Partners

q YES! Register me for this conference!

Name: _______________________________________________________

Title: ________________________________________________________

Company: ___________________________________________________

Dept.: _______________________________________________________

Address: ____________________________________________________

City: ______________________________ State: _____ Zip: __________

Email: _______________________________________________________

Phone: ______________________________________________________

Fax: _________________________________________________________

Method of Payment: q Check q Credit Card

Make checks payable to: ExL Events

Card Type: q MasterCard q Visa q Discover q AMEX

Card Number: ________________________________________________________

Exp. Date: ____________________________________________ CVV: _________

Name on Card: ______________________________________________________

Signature: ___________________________________________________________

Please contact me:

q I’m interested in marketing opportunities at this event.

q I wish to receive email updates on ExL Events’ upcoming events.

CONFERENCE CODE: C922

New Product PlanningSUMMIT

Improve early-stage decision-making, optimize lifecycle management and tailor product plans to ensure the successful commercialization of new drugs

December 7-8, 2017Revere Hotel Boston Common | Boston, MA2nd

Lisa Johnson-Pratt, M.D., Head, Early Pipeline

Commercial and Oncology Strategy,

GLAXOSMITHKLINE

David Xu, Executive Director, Head of New Product Planning,

PURDUE PHARMA

Gary L. Pyner, Chief Commercial Officer,

ASKLEPION PHARMACEUTICALS

Kasia Hein-Peters, Vaxelis Head of

Marketing, SANOFI PASTEUR

Ira Klein, M.D., MBA, FACP,

Senior Director of Healthcare Quality Strategy, Strategic Customer Group,

JANSSEN PHARMACEUTICALS

Elise Brownell, Ph.D., Executive Vice President, Operations and Project

Management,AMARANTUS

BIOSCIENCE HOLDINGS

CONFERENCECHAIRPERSON

Katja Wachtendonk, Global Director New

Products, NOVARTIS